Ichor Life Sciences

Ichor Life Sciences is a U.S.-operated preclinical contract research organization supporting biotechnology and pharmaceutical companies with drug research and development. Its services span the discovery pipeline, from gene-to-structure research and cellular screening to in vivo pharmacology and clinical trial support. The company combines a collaborative, customizable approach with broad scientific capabilities, emphasizing robust methods, reproducible experiments, and high-quality research.

Protein services include expression and purification across bacterial, yeast, insect, and mammalian systems, as well as structural biology, X-ray crystallography, and biophysical assays. Pharmacology offerings cover drug discovery and lead optimization, screening and assay development, cell-based studies, flow cytometry, histology, pharmacokinetics and pharmacodynamics, toxicology, and in vivo disease models. Ichor also provides formulation and DMPK services, plus clinical trial preparation, management, and close-out support. Consulting services include animal research and laboratory operations guidance. Its team works directly with clients to adapt studies to their needs, drawing on expertise across laboratory research, CRO operations, and clinical trial settings. Ichor’s mission is to help advance research that supports longer, healthier lives.